Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$6.88 USD
+0.15 (2.15%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $6.15 -0.73 (-10.61%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DAWN 6.88 +0.15(2.15%)
Will DAWN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DAWN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DAWN
Wall Street Analysts Believe Day One Biopharmaceuticals (DAWN) Could Rally 303.46%: Here's is How to Trade
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q1 Loss, Tops Revenue Estimates
DAWN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Jazz Stock Gains as Q4 Earnings & Sales Surpass Expectations
Day One Biopharmaceuticals, Inc. (DAWN) Reports Q4 Loss, Tops Revenue Estimates
Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect
Other News for DAWN
Day One Biopharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call Presentation
Day One Biopharmaceuticals outlines $140M–$150M 2025 OJEMDA revenue target as new patient scripts accelerate
Day One Biopharmaceuticals, Inc. (DAWN) Q2 2025 Earnings Call Transcript
Day One Biopharmaceuticals Non-GAAP EPS of -$0.29 beats by $0.05, revenue of $33.91M misses by $0.99M
Day One Biopharmaceuticals GAAP EPS of -$0.29, revenue of $33.9M